Tracking a muscle Drug's safety in the youngest patients
NCT ID NCT07154654
Summary
This study aims to collect long-term safety and usage information on the drug mexiletine in children under 6 years old who have myotonic disorders, which cause stiff muscles. Doctors will observe and record data from about 10 children already receiving this treatment as part of their normal care for at least two years. The main goal is to understand the drug's safety profile and how it is used in this very young age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOTONIC DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Hospitalier Universitaire de Clermont-Ferrand
RECRUITINGClermont-Ferrand, France
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.